Is iSpecimen Inc. (ISPC) a Buy, Sell, or Hold?
NASDAQ : ISPC
iSpecimen Inc.
$2.1 USD
-$0.11 (-4.98%)
- Volume
- 53.75K
- Average Volume
- 657.52K
- Market Capitalization
- $291.61K
- P/E Ratio
- -0.01
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $127.20
- Year Low
- $2.06
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.62
| Source | Headline |
|---|---|
|
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- E. F. Hutton and Co. ("E. F. globenewswire.com - 2026-05-12 14:16:14 |
|
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), an investment banking and financial advisory firm headquartered in New York City, today announced that it acted as the exclusive placement agent in connection with a $2.5 million private placement for iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers. globenewswire.com - 2026-05-12 14:16:00 |
|
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement
May 8, 2026 WOBURN, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it has priced a private placement with accredited investors for aggregate gross proceeds of approximately $2.5 million, before deducting fees to the placement agent and other offering expenses payable by the Company. globenewswire.com - 2026-05-08 21:04:00 |
|
iSpecimen Announces 1-for-40 Reverse Stock Split
Woburn, Massachusetts--(Newsfile Corp. - April 24, 2026) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it will effect a reverse stock split of its issued and outstanding shares of common stock, par value $0.0001 per share, as well as any shares of common stock held by the Company in treasury, at a ratio of 1-for-40. The reverse stock split will become effective at 4:30 p.m. newsfilecorp.com - 2026-04-24 09:00:00 |
